Home » Topics » BioWorld Science

BioWorld Science
RSS

T-614, a new NSAID that appears to act as a lysosomal protease inhibitor

Nov. 14, 1997

KE-298 suppresses MMP production in RA synoviocytes

Nov. 14, 1997

First interim phase III safety results reported for OxSODrol

Nov. 14, 1997

Selective collagenase 3 inhibitor shows promise for osteoarthritis

Nov. 14, 1997

Clinical safety and pharmacology of Vasoflux

Nov. 14, 1997

Na+/H+ exchange inhibitors isolated from Indonesian medicinal plants

Nov. 14, 1997

Synaptic: Q3 and nine-month highlights

Nov. 14, 1997

Texas Biotechnology: Q3 1997 highlights

Nov. 14, 1997

Onyx: Q3 1997 highlights

Nov. 14, 1997

Fujisawa: HY 1998 highlights

Nov. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.